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Abstract
In this work, we present a mathematical model of the initiation and progression of
a low-grade urinary bladder carcinoma. We simulate the crucial processes involved
in tumor growth, such as oxygen diffusion, carcinogen penetration, and angiogenesis,
within the framework of the urothelial cell dynamics. The cell dynamics are mod-
eled using the discrete technique of Cellular Automata, while the continuous processes
of carcinogen penetration and oxygen diffusion are described by nonlinear diffusion-
absorption equations. As the availability of oxygen is necessary for tumor progression,
processes of oxygen transport to the tumor growth site seem most important. Our
model yields a theoretical insight into the main stages of development and growth of
urinary bladder carcinoma with emphasis on two most common types: bladder polyps
and carcinoma in situ. Analysis of histological structure of bladder tumor is important
to avoid misdiagnosis and wrong treatment and we expect our model to be a valuable
tool in the prediction of tumor grade and progression patterns, based on the exposure
to carcinogens and an oxygen dependent expression of genes promoting tumor growth.
Our numerical simulations have good qualitative agreement with in vivo results re-
ported in the corresponding medical literature.
Keywords: Bladder cancer, cellular automata, nonlinear diffusion-absorption equation
∗corresponding author
Email addresses: svetlanabu@ariel.ac.il (Svetlana Bunimovich-Mendrazitsky),
vpisarev@gmail.com (Vladimir Pisarev), ekashdan@maths.ucd.ie (Eugene Kashdan)
Preprint submitted to Computers in Biology and Medicine August 25, 2014
1. Introduction
Bladder cancer (BC) represents an increasing health problem worldwide. It is esti-
mated that around 400,000 new cases are diagnosed annually and 150,000 people die
directly from BC each year. The highest incidence of BC occurs in the industrialized
and developed countries in Europe, North America, and Northern Africa. According to
the current statistics urinary bladder carcinoma is the fourth most common new cancer
in men and ninth in women [1].
A number of risk factors have been strongly linked to the development of BC.
Roughly 20% of all BC cases have been related to occupational exposure to chemi-
cals, mainly in industrial areas processing paint, dye, metal, and petroleum products.
Tobacco smoking is the main BC risk factor, accounting for at least 30% of BC cases.
Epidemiological and experimental evidence has also implicated environmental carcino-
gens in the aetiology of BC. Exposure to arsenic in drinking water has been recognized
as a cause of BC, for instance, in a study of long-term impact of arsenic pollution ob-
served in Chile. BC mortality was significantly higher in affected regions more than 20
years after cessation of pollution [2].
Based on the evidence of BC origins and the biological properties of the urothe-
lium, the first model of carcinogen penetration and BC initialization was proposed by
Kashdan and Bunimovich-Mendrazitsky [3]. In this model, the authors employed a
porous-medium-type equation to model carcinogen penetration and combined it with
the Cellular Automata (CA) simulation of cell dynamics. The original model [3] as-
sumed that the tissue was well oxygenated and the angiogenesis had not started. Thus
it aimed to simulate the BC initiation and the first steps of the superficial polyp growth.
It laid a basis of the high fidelity model presented in this manuscript that reproduces
the state and behavior of multiple mechanisms involved in BC development. The new
model introduces continuous oxygen and nutrient diffusion, and addresses hypoxia as
one of the regulating factors in the cell cycle for both normal and cancerous cells. In the
new model both carcinogen penetration under chronic exposure and oxygen diffusion
depend on the absorption properties of the particular cells. A mechanism of angiogene-
sis has been embedded in the new model allowing us to simulate tumor growth beyond
its initial stages.
Our research is based on the hypothesis that BC development is a multiscale multi-
level process. The “building blocks” of our model are: (i) carcinogen penetration into
the urothelium and (ii) oxygen diffusion, influenced by (iii) angiogenesis. These pro-
cesses are embedded into the CA model of urothelial cells dynamics. Our approach to
BC modeling corresponds with the multiscale studies of brain gliomas [4] and colorec-
tal cancer [5] that eventually led to novel therapeutic strategies to treat these diseases.
The first goal of our new mathematical model is to analyze various tumor devel-
opment scenarios leading to the development of the neovascular network (a process
known as angiogenesis). The second goal is to provide a basis for BC therapy person-
alization through the simulation of BC progression under various conditions. In the
numerical experiments presented in this manuscript, we discuss a number of scenarios
involving low-grade urothelial carcinomas such as superficial bladder polyp and car-
cinoma in situ (CIS). However, our model is not limited to these cases and it could
simulate the invasive form of BC in conjunction with the model of tumor invasion.
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Figure 1: The structure of human bladder.
The mathematical model of invasive BC is based on the interaction (and the com-
petition) between the matrix metalloproteinases (MMP), produced by the cancerous
cells, and the tissue inhibitors of metalloproteinases (TIMP), secreted by the tissue to
confront the tumor progression, was introduced and studied in [6].
The manuscript is organized as follows: In Section 2, we present general informa-
tion about the BC and the biological background of our model. After which we provide
the reader with the model framework, divided into three consecutive sections:
(a) The CA model of the urothelial cell dynamics (Section 3);
(b) Continuous processes, which correspond to oxygen diffusion and carcinogen
penetration (Section 4); and
(c) Modeling angiogenesis (Section 5).
Section 6 is dedicated to numerical simulations and a discussion of a number of
scenarios leading to tumor development and progression. We conclude our manuscript
in Section 7.
2. Biological background
2.1. Normal urothelium
A human bladder consists of the following layers: bladder lumen, urothelium, lam-
ina propria, muscle and fat [7, 8] as sketched in Fig. 1.
The urothelium is a highly specialized layer of epithelial cells lining the bladder. It
has to maintain a tight barrier against urea and other toxins, while accommodating large
changes in bladder volume. Under normal conditions the urothelium has a very low cell
turnover rate, however, when the urothelium is damaged it has to be able to repair itself
rapidly [7, 9]. The balance between the cell proliferation and differentiation controls
the cell replacement process.
The urothelium functions as a highly efficient barrier to the movement of water and
ionized substances across the bladder wall. The epithelial cells of the urothelium form
part of an integrated network, which plays a central role in bladder wall sensation, local
blood flow modulation, pathogen removal and active barrier provision.
The urothelium is composed of three to six layers of cells including basal cells,
intermediate cells and superficial (umbrella) cells (Fig. 2). Basal cells are germinal in
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Figure 2: The structure of the urothelium.
nature and approximately 5 µm to 10 µm in diameter. The basal cells are the only cells
in a normal urothelium that could proliferate and move between layers after differenti-
ation (if needed). The basal cells replace dead intermediate and umbrella cells by ac-
cepting the phenotype corresponding to each layer [7]. The cell replacement process is
discussed in more detail in the Section 3. The layer containing basal cells includes rare
normal stem cells, which have a potential to initiate tumor growth [10, 11]. It has been
well-established that tumor-initiating cells (stem cells, or stem-like cells), originating
from normal stem cells or from cells, which have transformed back from differenti-
ated cells due to mutations, are responsible for initiation, maintenance and metastasis
of numerous tumors including urothelial cancer (see review in [11]). Accumulation of
carcinogenic mutations in normal stem cells due to continuous action of environmental
carcinogenic compounds is crucial to initiate and drive the carcinogenesis due to the
altered expression of genes, affecting key signaling pathways of the cell. Most recent
studies have demonstrated that abnormal overexpression, even of one protein in stem
cells, within the basal urothelium in mice might generate an invasive lesion resembling
all patterns of human bladder carcinoma in situ [12].
Intermediate cells are located above the basal cells and are approximately 20 µm
in diameter. A layer of umbrella cells forms the luminal surface of the urothelium.
These cells are the largest epithelial cells in the body, measuring from 100 µm to
200 µm in diameter. The bladder urothelium shrinks (20–50%) during the urination
process. When the bladder fills the number of cell layers reduces as the cells flatten to
accommodate the stretching of the bladder wall [13].
As with any epithelial tissue, the normal (healthy) urothelium obtains oxygen and
nutrients through diffusion from the capillary network located in the lamina propria
and is separated from the urothelium by the basement membrane [7].
2.2. BC classification and grading
The most recent 2004 WHO classification distinguishes four grades of urothelial
tumors in accordance with their malignancy (from low to high) [7]:
1. Urothelial papilloma.
2. Urothelial neoplasm of low malignant potential.
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Figure 3: Patterns of urinary bladder carcinoma (Reproduced with publisher permission [7]).
3. Papillary urothelial carcinoma, low-grade.
4. Papillary urothelial carcinoma, high-grade.
In this work, we model the low-grade papillary urothelial carcinoma, however, our
approach is not limited to this type of BC and the model could be generalized to the
simulation of high-grade carcinoma as well.
There are four morphological patterns of bladder tumors (Fig. 3):
Our particular interest is with to the non-invasive papillary carcinoma (polyp) and
the flat non-invasive carcinoma (carcinoma in situ – CIS). The non-invasive polyp and
CIS carcinomas shown in Fig. 3 are responsible for approximately 75% of diagnosed
BC cases [14]. As sketched in Fig. 3(a), the noninvasive papillary carcinoma (polyp)
passes through the bladder wall into the bladder lumen but goes no deeper than the
lamina propria. On the other hand, CIS (Fig. 3(c)) remains within the urothelium. If
not treated properly, both polyp and CIS could transform into the far more dangerous
invasive forms. In Fig. 3, this corresponds to the (a)→ (b) and (c)→ (d) transforma-
tions. It is estimated that between 15% and 30% of low-grade carcinomas (Figs. 3(a)
and 3(c)) will progress to the high-grade (Figs. 3(b) and 3(d)) correspondingly [14].
Statistically, CIS has more chance to progress to high-grade (invasive) urinary bladder
carcinoma than the bladder polyp [15].
2.3. Tumor dynamics and carcinogenesis pathways
The main factor responsible for BC initiation is an accumulation of genetic alter-
ations (DNA mutations) in stem-like cells within the bladder urothelium, capable of
triggering aberrant signaling through key molecular networks involved in prolifera-
tion, differentiation and survival. Similar to other malignancies, it is likely that bladder
carcinogenesis involves aberrations in cell differentiation and proliferation, often with
the derangement in the genetic composition of malignant cells. Conversion of normal
urothelial cells to cancer cells and progression from the low-grade to the high-grade
muscle-invasive cancer are the result of the sequential acquisition of somatic gene mu-
tations [16]. We refer the reader to Table 1 in [18] for the list of the gene alterations
5
common in bladder cancer and to the scheme of molecular and genetic pathways for
bladder tumor classification in the reference [19].
Different carcinogens act on cells in different ways [20, 21]. However, they all have
certain aspects in common:
1. First, carcinogens all have the ability to damage the genetic composition of the
cell, either directly through DNA modifications, or through inducing gross chro-
mosomal abnormalities.
2. Second, the initial action of the carcinogen does not immediately cause the cell
to lose its growth controls (contact inhibition and organized growth patterns with
specific cell-cell adhesion). Such a pre-cancerous cell must undergo at least one
cell division in order to express the cancerous behavior condition. This DNA and
chromosome replication thus ”sets up” or initiates the carcinogenic behavior.
In case of BC, there are two pathways of carcinogen activation [22]. For several
compounds with carcinogenic or co-carcinogenic activities their accumulation could be
critical for dose-dependent, sequential accumulation of mutations in tumor-initiating
cells. Metal ions, proved to be accumulated in human tissues and to induce tumors
in vitro or in vivo, are prime candidates for such effects [23]. Prolonged exposure to
heavy metals including arsenic and cadmium were found to enhance mutagenicity and
carcinogenicity, or, even directly to induce malignant transformation of non-malignant
immortalized cells [23, 24, 25]. Evidence is growing that prolonged exposure to heavy
metals of gene expression profiles of epithelial cells is consistent with the malignant
phenotype of cells [26, 27, 28]. The metal traces quantification in bladder biopsies from
tumoral, non-cancerous areas, adjacent to tumors, and normal tissues, revealed signif-
icantly elevated levels of two carcinogens, arsenic and cadmium, in adjacent to tumor
areas [29]. The accumulation of metals and possibly other carcinogenic compounds in
the microenvironment might increase the likelihood of genetic instability and multiple
mutations of tumor-initiating cells located within the field of cancerization.
Another pathway is exposure to chemical carcinogens, for instance, aromatic amines,
associated with smoking [22]. These carcinogens are excreted in the urine and stored
temporarily in the bladder, where they have an extended opportunity to interact with the
urothelium. The gradual accumulation of chromosomal damage in the urothelial cells
eventually results in phenotypic expression and transformation into overt neoplasm.
These carcinogens form highly reactive electrophilic species that bind nucleic acid
and induce structural mutations within bladder epithelial cells. The observed changes
(which may vary in different cells) include allelic deletions, loss of heterozygosity,
inactivation of tumor suppressor genes or activation of proto-oncogenes.
One should note that increased carcinogen concentration could yield non-cancerous
gene alterations as well. However, in this manuscript we consider the mutation se-
quence that leads to the malignancy only. In fact, invasive and non-invasive forms of
BC correspond to the different sequences of the DNA mutations [17, 19]. According
to [17] it takes between three to five mutations for a cell to obtain a cancerous pheno-
type that corresponds to the superficial polyp or carcinoma in situ. This result agrees
with [18, 19], where four mutations are considered necessary to initiate development
of bladder cancer.
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Figure 4: Modeled slice of normal urothelium (a) and actual image of the fragment of the urothelium
obtained from cystoscopy [31] (b). The colors on the plot are as follows: (a) represent: dark blue – the
bladder lumen and the empty space inside the urothelium; light blue – ordinary (umbrella and intermediate)
urothelial cells; green – the basal cells; red – blood vessels; yellow – muscle and fat layers.
As highlighted above, BC is a complex phenomenon, which involves the number of
physical and biological processes. The main features responsible for BC development
and progression are:
(i) The alteration of tumor-initiating cell DNA due to the carcinogen penetration
from the bladder; and
(ii) The angiogenesis – a process leading to the development of a neovascular sys-
tem to provide growing tumor with additional oxygen and nutrients necessary for their
continuous proliferation [16].
Both these processes crucial for tumor development and growth are modeled in our
work. In our computational experiments, we investigate the possible role of insufficient
oxygen supply (hypoxia inducible factor – HIF) in the progression of the low-grade
urinary bladder carcinoma, and examine its expression in relation to the cell turnover
and the proliferation status.
3. Computational model of urothelial cell dynamics
We have chosen the Cellular Automata (CA) formulation for representation of cell
dynamics in the urothelium. CA allows us to model intuitively the critical parameters
governing tissue regulatory mechanisms: cell proliferation, apoptosis (cell death), and
dynamics of both normal and cancer cells [30]. All these mechanisms include a number
of sub-processes (i.e. maturation) that have also been taken into account. The basis
of our model is a slice of the bladder tissue as shown in Fig. 4 (a). Bladders size
estimations vary in the literature. The anatomy and physiology textbook [8] reports
average volume of bladder as 600mL. The approximate size of the urothelium cross-
section that we are looking on is 330mm× 0.2mm. In the numerical simulations we
consider a 4mm× 0.2mm fragment of the urothelium cross-section.
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The CA model consists of a two-dimensional array of automaton elements, which
will be eventually identified with the real urothelial cells, shown in Fig. 4 (b). The cell
characteristics change along the vertical axis representing the layers of the urothelium.
In our simulations, we consider the following morphological structure:
• The lumen layer is located in the top 9 rows. The bladder polyp cells grow there
vertically upwards by breaking through the bladder wall.
• The urothelium layer comprises the next ten rows of the lattice (i.e., rows 10–19).
• The lamina propria, where blood vessels reside, occupies two rows (20–21).
• The rows 22–30 represent fat and muscle layers to simulate the invasive type of
the BC.
The state vector represents cell dynamics of each CA cell. In the model imple-
mented in this work, the state vector has six components: (i) the site of the cells:
lumen, umbrella and intermediate layers (that we address as ordinary urothelial cells),
basal layer, lamina propria (where blood vessels reside), fat and muscle layer; (ii) occu-
pation status, i.e. whether the element is occupied by the normal cell, the mutated cell,
by the “empty space” or by the blood vessel; (iii) the cell status, i.e. whether the basal
cell is in the proliferative or in the interphase state; (iv) the carcinogen concentration;
(v) cancerous mutation counter of the cell; and (vi) oxygen and nutrients level.
The state vector evolves in time according to the prescribed local rules, used to
update any given element from its own state and that of its neighbors on the previous
time step. The structure called ”urothelium state” characterizes every cell and it is
filled during the numerical simulation. The CA model presented in this manuscript is
the enhanced and expanded version of the CA approach proposed in [3, 6]. The general
flowchart of the algorithm is shown in Fig. 5.
Our model represents differences in the behavior of normal (basal and ordinary)
and cancer cells as follows:
• Normal basal cells containing tumor-initiating cells: The stem cells of the
urothelium are located within the basal layer. The hypothesis that the basal cells
are routinely lost and replaced had been experimentally confirmed. Stem cells
behave as an equipotent population in which the balance between proliferation
and differentiation is achieved through frequent stem cell loss and replacement.
The cell division depends on the dynamics of clonal population and anatomic
constraints [32, 33].
Cell proliferation produces two cells from one, and it requires cell growth fol-
lowed by cell division. Uncontrolled cell proliferation is a hallmark of cancer.
Multiple mutations that accumulate in somatic cells over many years eventually
remove an elaborate set of controls that would otherwise prevent cancer cells
from dividing unchecked. In normal tissues, cell proliferation is generally re-
stricted to cells that replenish the tissue. Stem cells (including tumor-initiating
cells) are self-renewing cells that can divide asymmetrically to yield a new stem
cell and a progenitor cell [10]. Progenitor cells may or may not undergo further
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divisions, ultimately leading to terminal differentiation. Once cells have termi-
nally differentiated, they have a specialized function and are no longer dividing.
Most tissues are made up of such non-dividing cells. Thus proliferation is nor-
mally tightly controlled so that only particular cells in the body are dividing [34].
The average length of the cell cycle is 1 day, which corresponds to one iteration
in the CA algorithm.
The following CA rules (see also flowchart in the Fig. 6 are applied to each basal
cell as the algorithm progresses from the time-step i to the time-step i+ 1:
1. Cell death in urothelium (either necrosis or apoptosis) initiates the signal
for proliferation and provides nutritional support that reaches the basal level
containing stem cells. The experiments confirm that the injured or dying
cells might produce or liberate molecules signaling to the rare subsets of
stem or progenitor cells from the basal layer [35]. Provided that the signal
for empty place exists, and the cell is ready to proliferate, we turn the pro-
liferation flag on for the next iteration. A cell must replicate DNA (and its
various organelles) before it can divide, and there are many ways that a cell
can monitor its nutritional status and oxygen concentration; if nutrients and
oxygen are insufficient, it typically will not divide [34].
2. If more than one cell is ready for proliferation then the closest cell to the
empty space will be chosen; if more than one cell could fill the empty space
then the choice is made by “throwing the dice”. The process is detailed as
follows:
– If the oxygen level at the element occupied by the cell is above the
threshold L1, then we sample the region around the element in order
to determine whether the cell division occurs or not;
– If there is empty space, then the cell divides, and the new cell occupies
the empty space;
– If there is no empty space, the cell fails to divide, and will try to do it
on the next iteration.
3. If the cell is in the proliferative state, it will divide to form two daughter
cells, of which one will replace (renew) it, and another will move into the
“empty” site.
4. Every basal cell accumulates carcinogen; if carcinogen concentration passes
the threshold C1 we add one to the cancerous mutation counter; as soon
as the BC mutation counter is equal to four the cell obtains cancer phe-
notype and behaves according to the cancer cell mode described below.
Carcinogens yield various DNA mutations, many of which are not cancer-
ous. However, the mutation process is not entirely random. In [21], the
authors used the DNA sequence and copy number information to trace the
mutational evolution of individual tumors and to reconstruct the order of
abnormalities as individual tumors evolve for two separate cancer types.
Our assumption is that the concentration of carcinogen above the thresh-
old leads to the first of the mutations in the BC sequence and consequently
to the rest of mutations down the road. As confirmed by the experiments,
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the time-line of the mutations accumulation process could vary from few
days as result of a massive urothelial cell loss due to the bladder injury or
inflammation, to a number of years in case of the regular turnover of the
urothelial cells.
5. The daughter cells inherit the mutation counter and the carcinogen concen-
tration from their mother cell. There is no information, regarding propor-
tion of carcinogen inheritance between the daughter cells. However, as a
result of the chronic exposure to the carcinogens coming from outside this
value is not important. Due to the diffusive properties of the continuous
model of carcinogen penetration discussed in Subsection 4.2, the carcino-
gen concentration in every single cell is similar to the concentration in its
neighbors and the outliers are fixed within a few very short time-steps of
the continuous model.
In fact, the carcinogen penetration increases the probability of maligniza-
tion, but does not force it. The major reason behind BC is the accumulation
of genetic damage under effect of carcinogens that lead to the mutations. In
some cases, the DNA could be repaired and the cells could either survive or
die in this process. However, when the mutations necessary for carcinogen-
esis build up, and there exists a micro-environment (e.g., an inflammation
leading to the massive cell death), the tumor growth starts.
6. The basal cell has two oxygen concentration thresholds: L1 (enough for
proliferation) and L2 (sufficient for life, but insufficient for proliferation);
the oxygen level below L2 leads to the cell death from the hypoxia.
7. In order to differentiate, the basal cell should satisfy the following condi-
tions:
(a) The cell should be in the proliferative state;
(b) The cell should have sufficient oxygen concentration (above L1);
(c) The cell proliferation flag is turned on (as result of the appropriate
signal from the ordinary cell as described below).
• Ordinary (umbrella and intermediate) cells:
During physiological cell turnover, older differentiated cells are typically elim-
inated by apoptosis and replaced by the division progeny of stem cells. In fact,
the urothelium has one of the lowest turnover rates among mammalian epithelia,
estimated as once a year [36]. We set the threshold of the oxygen concentration
for the ordinary cell equal to L2 (same as for the basal cell). The CA rules are
applied to the ordinary cells as follows:
1. The dying cell sends a signal to the basal (stem) cells that the empty space
has emerged and could be filled;
2. The ordinary cell could die in three cases:
(a) apoptosis – natural death after 12 months [36];
(b) apoptosis under hypoxia – death due to the lack of oxygen (the oxygen
level is below L2) [37];
(c) necrosis – when the carcinogen concentration is above the threshold
C1 [38].
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• Cancer cells:
At each time step, the CA algorithm checks the carcinogen concentration for
every cell. If the concentration passes the threshold level the first mutation is
registered in accordance with [39]. Different carcinogens have different muta-
tion threshold values. Therefore simultaneous exposure to multiple carcinogens
could significantly accelerate mutations rate. The DNA mutations caused by
carcinogens may occur in any cell of the urothelium. However, in ordinary cells
they yield the cell death. Only stem cells located in the basal layer can transfer
their genetic alterations to the daughter cells, which in their turn might even-
tually become cancerous following the number of cell divisions [38]. Thus we
examine mutations on the basal layer only.
The cancer cell behaves according to the following set of rules:
1. The cancer cells can differentiate anywhere in urothelium and they compete
with the normal cells for empty space;
2. A tumor cell could survive with concentration of carcinogen above C1;
3. Cancer cells have their own oxygen thresholds: if the oxygen level in the
cancer cell is less than L3 it produces a signal, which is sent to the vascular
system in order to start sprouting of blood cells towards the area with the
lack of oxygen. This process is known as an angiogenesis – see Section 5.
In this case, the cancer cell cannot proliferate;
4. If the oxygen concentration is below L4 the cancer cell enters the hypoxia-
induced dormancy state for one year and only after that, if the oxygen sup-
ply does not increase above the threshold, the cancer cell dies.
This rule corresponds to a well-known, but not exclusive, feature of cancer
cells – their ability to enter a quiescent state under hypoxic conditions, in
which they suspend all activity, including any cell division that is not essen-
tial for survival [40]. The duration of the hypoxia-induced dormancy state
varies between approximately 2 months and 1 year depending on the can-
cer. There is also difference between in vivo and in vitro experiments [41].
However, we have found numerically that varying this parameter between 9
months and 1 year (an estimated range for tumor-initiating epithelial cells)
has very little impact on tumor progression due to renewed oxygen supply
via the angiogneic network of blood vessels.
To summarize behavior of each type of cells we include the flowcharts describing
the corresponding CA rules.
3.1. Interaction between the models
At each time step the CA model interacts with the continuous models of carcinogen
penetration and oxygen diffusion by supplying them with the state vector information
and obtaining the levels of carcinogen and oxygen concentration correspondingly as
shown in Fig. 8.
Before we move to the next section describing continuous processes we want to
point out that the CA state vector does not address the cell size. On the other hand,
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Figure 5: The CA rules corresponding to the state vector evolution. Car c and Mut N represent the carcino-
gen concentration level and the mutation counter respectively; C1 is the carcinogen threshold from Table
1.
Normal basal cell owchart
Figure 6: The CA rules corresponding to the basal cell proliferation rules. O2 is the oxygen concentration.
L1 and L2 correspond to the oxygen thresholds for normal cells, given in Table 1. L1 is the proliferation
threshold and L2 is the apoptosis under hypoxia threshold.
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Figure 7: The CA rules corresponding to the cancer cell proliferation rules. O2 is the oxygen concentra-
tion level. L3 and L4 correspond to the oxygen thresholds for cancer cells, given in Table 1. L3 is the
proliferation threshold and L4 is the dormancy state threshold.
Carcinogen
penetration
model
t=0
t=Δt
CA update at t=iΔt
CA update at t=(i+1)Δt
Carcinogen 
concentration 
level
State vector correction
Oxygen 
di!usion
model
t=0
t=Δt
Oxygen 
concentration
level
State vector
including new blood
cell location due 
to angiogenesis
State vector
Figure 8: Combination of the discrete CA model of urothelial cell dynamics with the continuous models of
carcinogen penetration and oxygen diffusion. ∆t is a period of time between updates of the cell states in
accordance with the CA rules. i is the number of iteration (update). The data transferred between the models
is detailed in Section 6 dedicated to numerical experiments.
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the simulation of continuous processes runs on a separate rectangular grid, where the
actual urothelial cell could correspond to one or more grid cells.
4. Continuous processes
4.1. Oxygen diffusion
One of the major features of the normal urothelium (and any other transitional
epithelium) is the absence of blood vessels. The blood vessels are located in the lam-
ina propria, underneath the epithelial tissue. The lamina propria is separated from
the epithelial tissue by the basement membrane. The oxygen and nutrients reach the
urothelial cells through passive diffusion.
We describe the process of oxygen diffusion using the nonlinear diffusion-reaction
equation, based on the porous-medium equation with the absorption term:{
∂tu−∇[D(~x, t)∇(|u|
m−1u)] + h(t)|u|q−1u = f(~x, t) in QTN ,
u(~x, 0) = kδ0 .
(1)
We call u(~x, t) the concentration of oxygen measured in [amount of oxygen per cell vol-
ume]=[mol/L]. The diffusion coefficient mD(~x, t)|u|m−1 > 0 has dimensions of [cell
area on lattice per unit of time]=[cm2/s] and it is proportional to the degree m− 1 of
u, where m >1. When m = 1, we have linear diffusion, which has infinitely fast speed
(impossible from the biological point of view). While D is usually known or could
be measured, the value of m corresponds to the speed of diffusion and it is adjusted
using numerical experiments. Cells can absorb water, oxygen or even salt through pas-
sive transport. The plasma membrane allows relatively small molecules to enter and
exit the cell, but does not allow larger molecules to pass. To simulate this process we
add non-differentiated absorption term qh(t)|u|q−1 > 0, the units of which are [s−1].
The rate of absorption is proportional to the degree q − 1 of concentration (q > 1),
which is also adjusted in numerical experiments. Initially oxygen concentration is ran-
dom within the urothelium and is maximal in the blood vessels within lamina propria.
This situation is represented by the initial condition and the source term f(x, t). The
changes in oxygen diffusion that correspond to angiogenesis are discussed in Section
5.
We assume that both D and h are piecewise continuous, non-negative functions,
representing the diffusion and the absorption coefficients correspondingly;m and q are
positive real numbers representing the speed of diffusion and absorption in their turn;
k is a non-negative constant matrix of the same size as the lattice and δ0 is the Dirac
delta function that represents the source at time t = 0. The evolution of source in
time and in space is given by f(~x, t). Our domain of interest QTN is a two-dimensional
space-time continuum (N = 2). Equation (1) has a non-negative solution associated
with the physics of the model. Another important feature of this equation is the finite
speed of diffusion, which cannot be simulated in the linear model [42].
Equation (1) was studied theoretically in [43]. The authors first considered the case
whenD ≡ 1, h ≡ 0 andm > (N−2)/2 and defined a corresponding solutionBk(x, t)
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for any k > 0 (here k corresponds to the initial condition of (1)):
Bk(x, t) = t
−l
(
Ck −
(m− 1)l|x|2
2mNt2l/N
)1/(m−1)
(2)
where
l =
N
N(m− 1) + 2
, Ck = a(m,N)k
2(m−1)l/N ,
and a(m,N) is a free parameter. Note that Bk(x, t) is also known as “Barenblatt
solution” [42].
Since Bk is a supersolution for problem (1), a sufficient condition for existence
(and uniqueness) of uk is ∫∫
QT
Bk(x, t)h(t)dxdt <∞ . (3)
By change of variable y = tl/Nx, this condition becomes independent of k > 0. The
authors in [43] have proved that if
∫ 1
0
h(t)tl−lqdt <∞ , (4)
when m > 1, q > 0, then the problem (1) admits a unique positive solution u = uk.
The oxygen diffusion model allows us to investigate the possible role of HIF in the
recurrence and the progression of low-grade urinary bladder carcinoma, and to examine
its expression in relation to proliferation status, cell death and angiogenesis [45].
4.2. Carcinogen penetration
The carcinogens mixed with the solute, in the form of biofluid, penetrate through
the bladder wall into the deep layers of urothelium. If the carcinogen concentration
inside the basal cells passes certain threshold, it triggers the chain of mutations, leading
potentially to the cells with the cancerous phenotype. Here we summarize the number
of assumptions we made to model the penetration process in accordance with [46]:
1. The carcinogen is accumulating on the bladder wall;
2. The carcinogen penetrates slowly through the layers of urothelium and its con-
centration reaches mutation threshold level in the years-long span;
3. Cell loss (both apoptosis and necrosis) leads to the “empty space” in the lattice
with no carcinogen [44].
In this work we generalize the model of carcinogen penetration suggested in [3].
Carcinogen penetration is modeled within the same mathematical framework as oxygen
diffusion (equation (1)) and defined on the same physical domain – two-dimensional
lattice QTN , which corresponds to the one-cell-thick slice of the urothelium. However,
diffusion and absorption coefficients for carcinogen penetration are different and cor-
respond to the values obtained from the toxicology studies as detailed in Table 2. The
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carcinogen concentration is measured as [amount of solute per cell volume]=[mol/L].
The speed of carcinogen penetration is much slower than the speed of oxygen diffusion,
as reflected in the corresponding coefficients in Table 2. It has been proven experimen-
tally (see, for instance, [47]) that majority of carcinogens are absorbed through simple
passive diffusion. The degrees of proportionality m − 1 and q − 1 of diffusion and
absorption coefficients are adjusted experimentally as well. The concentration of car-
cinogens on the bladder wall is random throughout the simulation and it is updated at
the beginning of each CA time-step.
5. Angiogenesis
The tumor cannot grow beyond the certain size (usually, 1–2 mm3) by exploiting
resources of the urothelium [48]. Its further growth requires additional oxygen and nu-
trients provided by the neovascular network developing towards the tumor (a process
known as angiogenesis). These new blood vessels have a very chaotic structure and
have a higher permeability compared to the regular vascular system. The new blood
vessels are more leaky and carry with them less oxygen and nutrients than the regular
blood vessels. However, they provide surrounding normal and cancer cells with eas-
ier access to oxygen and nutrients than the blood vessels lying in the lamina propria.
Angiogenesis is playing a very important role in both low-grade and high-grade BC
[45, 49].
Responding to the insufficient oxygen supply the cancer cells overexpress and acti-
vate HIF (specifically, HIF-1α). The latter activates expression of vascular endothelial
growth factor (VEGF), the secreted protein capable of signaling towards the lamina
propria. VEGF is one of the key angiogenic factors that stimulates formation of the
new blood vessels and tumor growth [50]. Elevated levels of VEGF expression were
detected in the urine samples from the BC patients and correlated with the disease re-
currence and progression [49]. In agreement with this study, a high level of the VEGF
expression that was present in tumors and in serum samples from patients with BC,
also predicted a poorer prognosis and an increased frequency of disease recurrence
[45]. Interestingly, simultaneously to promoting angiogenesis via VEGF, HIF-1α pro-
motes invasion of malignant cells through tissues via other mechanisms. Therefore, the
increased angiogenesis might associate with both increased rate of tumor growth and
promotion of invasion processes, two main markers of a disease progression.
Our approach to the simulation of angiogenesis could be described as follows:
1. The mutated cell has obtained cancer phenotype, but it does not have sufficient
amount of nutrients and oxygen necessary for proliferation (oxygen level below
L3).
2. The cell sends the VEGF signal to the vascular network located in the lamina
propria.
3. As soon as the VEGF signal reaches the closest cell in lamina propria; the blood
vessels start to branch away from this cell and work as a source of oxygen and
nutrients for all surrounding cells with increased diffusion coefficient due to its
high permeability [48].
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4. On each CA time step, the blood vessels grow towards the cancer cells by cap-
turing empty space or replacing (killing) basal and ordinary cells located on their
path.
The tip cells of the angiogenic sprouts secrete enzymes such as matrix metallo-
proteinases (i. e., MMP-9) that lead to the degradation of the extra-cellular ma-
trix (ECM) and eventual death of the cells lying on the pass between the newly
formed blood vessels and the developing tumor [51, 52]. One should also notice
that MMPs help degrade the proteins that keep the vessel walls solid [53].
5. Other cancer cells experiencing lack of oxygen send the VEGF signal that could
reach either lamina propria or newly formed vessels and start new sprouts, effec-
tively building the angiogenesis tree.
The structure of the neovascular network depends on the type of BC [54]. The new
vessels are confined within the polyp when it grows into the bladder lumen and they
eventually kill the tumor cells.
As result of the angiogenic activity the urothelium looses its elasticity resulting in
blood leaking into the bladder that is usually detected through the discovery of blood
traces in the urine sample.
6. Numerical simulations
6.1. Settings
In order to simulate BC growth on computer we make the number of assumptions
in addition to ones discussed in the previous sections:
• We simulate general characteristics of carcinogen penetration and tumor devel-
opment process on the one-cell-thick layer of the urothelium, which is, in fact, a
two-dimensional lattice, however, we ignore the geometry of the cell.
• We assume that an ordered sequence of four specific mutations is sufficient for
basal cell to obtain a BC phenotype [17, 18, 19].
• In our experiments, angiogenesis is regulated by HIF [49]. We simulate the
effect of hypoxia on ordinary, basal and cancer cells by setting the corresponding
oxygen level thresholds (see Table 1).
The threshold values in Table 1 are given as references. They had been estimated
for the US Environmental Protection Agency (USEPA) using the methodology detailed
in [55].
Table 1 is used to connect between the CA and the models of continuous processes
as shown in Fig. 8. On each CA iteration, the actual values of oxygen level and
carcinogen concentration are checked against the threshold values for each cell. The
changes in the cell state vector (e.g., cell status and mutation counter) are introduced
then.
In the simulation of continuous processes, we consider an xy-plane, such that the
horizontal x-axis goes along the layers and the vertical y-axis goes down through the
layers of urothelium. We assume that the carcinogens penetrate from top to bottom
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Name of the threshold Value, [mol/L] References
Oxygen concentration level L1 (above:
sufficient for basal cell proliferation) 4.5× 10−4 [56]
L2 (above: sufficient for life for both Estimated
ordinary and basal cells, but insufficient as 1/3 of L1
for basal cell proliferation; below: ordinary following
and basal cell apoptosis under hypoxia) 1.5× 10−4 [34]
L3 (above: sufficient for cancer
cell proliferation) 4.5× 10−5 [30]
L4 (above: sufficient for cancer cell
life, but insufficient for its proliferation;
below: cancer cell enters the sleeping
state for 1 year and dies after that.) 1.5× 10−5 [30]
Carcinogen concentration level C1
(mutation threshold in the basal cells and
necrosis threshold in the ordinary cells) 1.5× 10−4 [57]
Table 1: The threshold values used in the CA model.
(with exception of bladder polyps); the oxygen diffusion starts from bottom, but could
eventually start and go in any direction following development of the neovascular net-
work due to the angiogenesis. In the BC scenarios discussed in this work, the tumor
grows towards the bladder lumen and yields a polyp or remains within the urothelium
forming a CIS.
The diffusion coefficients for both carcinogen penetration and oxygen diffusion
models (summarized in the Table 2) are piecewise constant, and their values depend on
the cell type. Newly formed blood vessels have very high permeability [48], as result
they do not curry as much oxygen and nutrients as regular vessels. Using the available
data (see also [58]) we estimate their oxygen concentration is half that of the oxygen
concentration in regular blood vessels.
The absorption (uptake) coefficients are equal to 0.1s−1 for oxygen diffusion model
[59] and to 1s−1 for carcinogen penetration model [60].
There is no clear rule on choosing parameters m and q for each of the models.
So we consider m = q = 2 for carcinogen penetration, which brings it in line with
the classical Porous Medium Equation. Oxygen diffusion is modeled with m = 2
and q = 3. In practice, these two processes have a different time scale: carcinogen
penetration is a very slow process, while oxygen diffusion is supposed to be much
faster [61].
In our numerical experiments, we consider a small part of the urothelium – a rect-
angular slice that corresponds to ∼ 2000 cells (roughly 2% of the urothelium cross-
section). In order to avoid numerical artifacts leading to increased carcinogen concen-
tration and fast tumor growth near the boundaries we add so called buffer layers from
both sides of the computational domain.
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Cell type Oxygen diffusion Carcinogen penetration
[cm2/s]×10−5 Reference [cm2/s]×10−5 Reference
Empty space
in lattice 4.6 (a) 1.35 (b)
Bladder lumen 0.6 Based on (a) 0.4 (b)
Muscle and fat 2.1 (c) 0.01 *
Normal 1.82 (d) 0.486 (e)
Cancer 1.29 (f) 1.0 **
Blood cells
(in lamina propria) 1.06 (f) 0.176 (g)
New blood cells
(angiogenesis) 4.25 (f,h) 0.7 Based on (g)
Table 2: The diffusion coefficients for various cell types used in the simulation of continuous processes. The
references are: (a) Androjna et al., Tissue Engineering A 14(4), (2008), 559–569, (b) J. Pfeuffer et al., J. of
Cerebral Blood Flow and Metabolism 20(4) (2000), 736–746, (c) T. B. Bentley et al., Am. J.. of Physiology
264, (1993) H1825, (d) R. Venkatasubramanian, et al., J. of theoretical biology 242(2) (2006), 440–453, (e)
E. Selard et al., Spine 28, (2003), 1945–1953, (f) K. L. Weind, et al., Am J Physiology, 281, (2001) H2604,
(g) O. Boubriak, and J. P. G. Urban, J. of Bone and Joint Surgery, 84(I), (2002): 93-d, (h) B. M. Fu, et al.,
J. of biomechanical engineering 127(2), (2005), 270–278, (∗) Estimation based on H. Sorbye et al., Dig Dis
Sci. (1995) 40(12), 2509–2515, (∗∗) Estimation based on J. P. Berry et al, Ann Clin Lab Sci, (1985) 15(2)
109–120.
In normal urothelium, the carcinogens are almost not penetrating below the lamina
propria. The effect of carcinogen penetration into the fat and muscle layers and further
deep into the surrounding tissues is related to the MMPs secreted by the cancer cells
following a specific chain of mutations modeled in [6].
We consider the oxygen concentration within the regular blood vessels to be equal
to 5.175 × 10−3mol/L at the beginning of each CA time-step [62]. The carcino-
gen on the bladder wall is uniformly distributed and its maximum is estimated as
3× 10−6mol/L, which corresponds to the average cotinine concentration in the urine
of the active smokers [63]. Cotinine, a nicotine metabolite, is a biomarker of tobacco,
nicotine, and carcinogen exposure.
The equation (1) is solved numerically by the 4th order finite difference algorithm
for integration in space and the 4th order Runge-Kutta scheme for advancing in time
[64]. The algorithm is able to handle a situation when the carcinogen concentration
within the solute changes rapidly and sharply. We also did a perturbation analysis to
confirm that small changes in parameter values do not lead to significant changes in the
outcome of our numerical simulations. The temporal resolution of continuous models
is chosen to ensure the stability of numerical solution. In physical terms it is equal to
∼ 4 min. (duration of one CA iteration is 24 hours). A very small artificial viscosity is
added through the fourth order spatial derivative (with coefficient of order 10−9).
The CA simulation of cell dynamics and models of carcinogen penetration and
oxygen diffusion could have the same (one cell) spatial resolution. However, in general,
a single cell of urothelium (a basic unit of the CA model) could be represented by the
number of nodes on the grid used for carcinogen penetration or/and oxygen diffusion
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Figure 9: Snapshot from the simulation of polyp growing into the bladder lumen (a) and image of polyps
from the cystoscopy provided as reference (http://healthtap.com) (b).
modeling. In such a case, the levels of carcinogen concentration and oxygen diffusion
transferred to the CA model are averaged inside the corresponding urothelial cell.
The time span of both continuous models is corresponding to the single time-step of
the CA, which is equal to one day in our experiments. As shown in Fig. 8, the contin-
uous models update the cell state vector in CA model and obtain the initial conditions,
the values of coefficients and the values of carcinogen and oxygen concentration levels
from the previous time step.
In the next sections we discuss numerical simulations representing two common
scenarios of BC progression: bladder polyp and CIS.
6.2. Bladder polyp
Bladder polyps are the most common form of the urinary bladder carcinoma. Their
main macroscopic features are single or multiple exophytic papillary masses [65]. In
our simulations, we follow the process of polyp formation starting from the clones
of mutated cells within the urothelium. Growth of polyps is always supported by the
angiogenesis [16] and it is also reflected in our experiments. As we have already stated
in Section 2, BC development and progression is a long multi-year process. In the
bladder polyp scenario presented in this work we make the 85 months snapshots of cell
status (Fig. 9(a)) and carcinogen penetration and oxygen diffusion (Figs. 10(a) and
10(b) respectively). By that time we have two full grown polyps within the bladder
lumen and the number of smaller polyps of various sizes. The similar scenarios are
often observed during bladder polyp removal surgery.
The neovascular network (shown in red in Fig. 9(a)) grows through the urothelium
toward the polyp and eventually ruins the layered structure of urothelium and changes
its physical characteristics. Our simulation reflects an important morphological feature
of angiogenic behavior in the bladder polyp form of BC: the blood vessels grow within
the polyp [54]. One more observation corresponds to the particular BC scenario run
in the simulation: most basal cell have already obtained the cancer phenotype by the
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Figure 10: Concentration of carcinogens within the urothelium (a) and oxygen level (b) corresponding to the
the simulation of bladder polyp in Fig. 9(a).
snapshot time. It means that the surgical removal of polyp and its neovascular network
will not eradicate BC. With high probability, the urothelial cells damaged during the
surgery and the post-surgery treatment will be replaced by the cancerous cells. New
polyps will continue to grow, and the BC remission is the expected follow-up scenario.
The carcinogen concentration in Fig. 10(a) is highest for umbrella cells. This
reflects the role of umbrella cells within the urothelium: to slowdown the penetration
process and prevent from the carcinogens reaching the basal cells. One can observe
from Fig. 10(a) that the carcinogens are also absorbed by the polyps.
The oxygen level in Fig. 10(b) mimics the geometry of polyps and corresponds
to their morphology. The new blood vessels formed as the result of the angiogenic
activity provide the cancerous cells with oxygen and nutrients sufficient for the polyp
growth.
6.3. Carcinoma in situ (CIS)
The CIS is caused by the different chain of mutations than the polyp [19]. In
Fig. 11, we show the CIS modeled using our approach (a) and the cross-section of
CIS from the cystoscopy (b). On the in vivo images the CIS is marked by brown
color and one can see that it spreads within the urothelium barely leaving the umbrella
cells. According to [65], the major macroscopic properties of the CIS are granular or
cobblestone appearance (as seen in Fig. 11(b)) and multifocality.
One can also see that our simulation has also captured a major morphological char-
acteristics of CIS: its “mushroom-like shape”.
7. Discussion and future work
In this work, we have presented an in silico model of urinary bladder carcinoma
development and growth. In our simulations, we demonstrated the cell dynamics cor-
responding to the development of low-grade BC in form of bladder polyps and CIS.
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Figure 11: CIS: numerical simulation (a), cystoscopy image from http://pathologyoutlines.com (b).
The main purpose of our numerical experiments was to study the effects of carcinogen
penetration and hypoxia and to understand the role the angiogenesis is playing in the
BC progression.
In our previous work [3, 6], we introduced a framework that combines discrete and
continuous models to describe quantitatively the BC initiation. However, the current
model represents a major revision of our approach and its significant extension. It
allows us to simulate bladder carcinogenesis from the initial mutations to the full-size
tumor. The nonlinear submodel of oxygen diffusion and the CA-based submodel of
angiogenesis, presented in this manuscript, could be used for modeling and simulation
of various cancers, originating in epithelial cells.
One of the major challenges in cancer urology is to provide a prognosis of tumor
development for a patients based on the information collected from the cystoscopy and
the initial treatment. If such a prognosis could be done early in the course of disease,
those with a high likelihood of BC recurrence or progression could be treated more
aggressively. A histological examination is used to predict the probability of recurrence
and the progression of low-grade urinary bladder carcinoma. From the analysis of the
cell structure, the pathologist determines the stage, grade, and multiplicity of tumor.
However, the accuracy of such an examination depends on the pathologist’s experience.
The current consensus is that these tumors evolve down one of two major genetic
pathways. The first is associated with low-grade papillary and non-invasive cancers
that infrequently progress to invasive BC. The other is typified by in situ or higher
grade superficial tumors that frequently recur and progress to higher grade and muscle
invasive disease [66]. Given individual patient data and genetic analysis of the biopsy,
our model will be able to comprehend the diagnostics process by analyzing various
scenarios of tumor behavior and make both qualitative and good first-order quantitative
predictions of tumor development.
Bladder tumors have diverse morphology [14] and this situation significantly com-
plicates their diagnosis. In many cases, BC may contain variable proportions of dif-
ferent histologic patterns. The clinical outcome of some variants differs from that of
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typical urothelial carcinoma and may call for different therapeutic approach. Pathol-
ogists should also be aware of the incidence and histologic appearances of secondary
neoplasms of the urinary bladder, with emphasis on the points of distinction from pri-
mary tumors and their histologic variants [67]. Comparison of the computer-predicted
and actually observed tumor patterns may help clinicians with better understanding of
tumor histology and planning of treatment strategy.
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